Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.1234 per EA under NDC 60687067265. Its NADAC has been published 195 times since Nov 9, 2022.
FDA first approved this application on Aug 27, 2003.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET
Butalbital, Acetaminophen, and CaffeineStrength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
American Health PackagingNDC
60687067265
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA040511FDA Approved
8/27/2003
On Market Since
10/17/2022
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has been published 195 times since Nov 9, 2022, and over the history we have for it it has declined 30.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1234 per EA |
|---|---|
| All-time high | $0.1767 (Nov 16, 2022) |
| All-time low | $0.1112 (Nov 20, 2024) |
| 52-week high | $0.1398 |
| 52-week low | $0.1218 |
| Median price | $0.1489 |
| Average price | $0.1449 |
| Largest weekly change | +35.2% (Aug 21, 2024) |
| Weeks tracked | 195 |
| Tracking since | Nov 9, 2022 |
1W
N/A
1M
N/A
3M
+1.3%
6M
-5.8%
1Y
-10.3%
3Y
-19.7%
5Y
N/A
All
-30.1%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Butalbital, Acetaminophen, and Caffeine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Barbiturate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, manufactured by American Health Packaging, is $0.1234 per EA (NDC 60687067265), effective Jul 29, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has declined 30.1%. It has been tracked across 195 weekly CMS publications since Nov 9, 2022.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
Since Nov 9, 2022, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has ranged from a low of $0.1112 (Nov 20, 2024) to a high of $0.1767 (Nov 16, 2022), with a median of $0.1489 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, is $0.1223 per EA — about 1% below BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET (NDC 60687067265) is labeled by American Health Packaging, and CMS classifies it as a generic product.